TNFSF11 Rekombinanter Antikörper
TNFSF11 Rekombinant Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
Maus
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241791B7
Kat-Nr. : 84431-5-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84431-5-PBS bindet in WB, IHC, Indirect ELISA TNFSF11 und zeigt Reaktivität mit Maus
| Getestete Reaktivität | Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | TNFSF11 fusion protein Eg1956 |
| Vollständiger Name | tumor necrosis factor (ligand) superfamily, member 11 |
| Berechnetes Molekulargewicht | 35KD |
| Beobachtetes Molekulargewicht | 22 kDa |
| GenBank-Zugangsnummer | NM_011613.3 |
| Gene symbol | Tnfsf11 |
| Gene ID (NCBI) | 21943 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
TNFSF11, known as Tumor Necrosis Factor Superfamily Member 11, also known as RANKL (Receptor Activator of Nuclear Factor-κB Ligand), TRANCE, etc., is a member of the Tumor Necrosis Factor (TNF) superfamily.RANKL is a type II homotrimeric transmembrane protein located primarily at the plasma membrane. RANKL is a type II homotrimeric transmembrane protein located mainly at the plasma membrane, and in addition to the membrane-bound form (mRNAKL), it can also be cleaved by proteolytic cleavage of the cell membrane to produce the soluble form (sRANKL). The membrane-bound form of RANKL is the main form involved in triggering the RANKL/RANK signaling pathway and mediating osteoclastogenesis. Current studies have shown that TNFSF11 acts primarily in the immune and skeletal systems and has been implicated in the pathogenesis of degenerative bone diseases, carcinogenesis, and asthma.





